The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.2 - Manufacture of pharmaceutical preparations
90 jobs Number of planned job losses
Announcement Date
7 July 2014
Employment effect (start)
7 July 2014
Foreseen end date
Description
As announced on 7 July 2014, pharmaceuticals producer Actavis is to cut 90 jobs at its site in Weiterstadt. According to newspaper reports, the job cuts will make more than every fourth job redundant.
According to the management, job cuts were due to decreasing production. In Weiterstadt, Actavis prepares a drug against Crohn’s disease and packs a drug against osteoporosis. There is no information available on the end date of the measure.
All German and several Western European sites were acquired by Indian Aurobindo in January 2014. Originally from Island, Actavis is an international company with around 10,500 employees.
Sources
7 July 2014: FAZ
Citation
Eurofound (2014), Actavis, Internal restructuring in Germany, factsheet number 77318, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/77318.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
